Prudential Financial’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.9M Sell
55,482
-671
-1% -$130K 0.01% 599
2025
Q4
$9.74M Sell
56,153
-6,813
-11% -$1.24M 0.01% 633
2025
Q3
$12M Sell
62,966
-854
-1% -$152K 0.01% 594
2025
Q2
$11.5M Buy
63,820
+3,740
+6% +$650K 0.01% 598
2025
Q1
$10.2M Sell
60,080
-272,656
-82% -$44.8M 0.01% 585
2024
Q4
$50.2M Sell
332,736
-79,651
-19% -$12.4M 0.07% 216
2024
Q3
$64M Buy
412,387
+341,888
+485% +$51.1M 0.09% 194
2024
Q2
$9.65M Sell
70,499
-21,815
-24% -$2.99M 0.01% 656
2024
Q1
$12.3M Buy
92,314
+8,832
+11% +$1.15M 0.02% 605
2023
Q4
$11.5M Sell
83,482
-19,658
-19% -$2.58M 0.02% 614
2023
Q3
$12.6M Sell
103,140
-2,797
-3% -$373K 0.02% 575
2023
Q2
$14.9M Sell
105,937
-4,556
-4% -$628K 0.02% 530
2023
Q1
$15.3M Sell
110,493
-1,661
-1% -$238K 0.02% 505
2022
Q4
$17.5M Sell
112,154
-5,120
-4% -$736K 0.03% 462
2022
Q3
$14.5M Sell
117,274
-1,383
-1% -$182K 0.02% 524
2022
Q2
$16.2M Sell
118,657
-2,286
-2% -$311K 0.03% 515
2022
Q1
$16.6M Sell
120,943
-4,541
-4% -$633K 0.02% 561
2021
Q4
$19.2M Sell
125,484
-1,026
-0.8% -$156K 0.02% 520
2021
Q3
$19.2M Sell
126,510
-63,801
-34% -$9.34M 0.03% 489
2021
Q2
$25.1M Sell
190,311
-82,551
-30% -$10.8M 0.03% 429
2021
Q1
$35M Buy
272,862
+72,753
+36% +$8.96M 0.05% 314
2020
Q4
$23.8M Buy
200,109
+82,984
+71% +$10.1M 0.04% 391
2020
Q3
$13.4M Buy
117,125
+6,439
+6% +$761K 0.02% 545
2020
Q2
$12.6M Sell
110,686
-35,175
-24% -$3.73M 0.02% 601
2020
Q1
$11.7M Sell
145,861
-5,867
-4% -$607K 0.03% 578
2019
Q4
$16.2M Sell
151,728
-1,535
-1% -$160K 0.02% 661
2019
Q3
$16.4M Buy
153,263
+26,233
+21% +$2.69M 0.03% 619
2019
Q2
$12.9M Buy
127,030
+1,934
+2% +$186K 0.02% 722
2019
Q1
$11.2M Sell
125,096
-25,961
-17% -$2.25M 0.02% 786
2018
Q4
$12.6M Sell
151,057
-4,147
-3% -$389K 0.02% 718
2018
Q3
$16.7M Sell
155,204
-5,518
-3% -$605K 0.02% 699
2018
Q2
$17.7M Buy
160,722
+2,333
+1% +$243K 0.03% 681
2018
Q1
$15.9M Sell
158,389
-37,563
-19% -$3.85M 0.02% 711
2017
Q4
$19.3M Sell
195,952
-132,024
-40% -$12.5M 0.03% 658
2017
Q3
$30.7M Buy
327,976
+117,720
+56% +$12.5M 0.04% 478
2017
Q2
$23.4M Sell
210,256
-2,548
-1% -$269K 0.03% 554
2017
Q1
$20.9M Sell
212,804
-7,710
-3% -$735K 0.03% 582
2016
Q4
$20.3M Sell
220,514
-3,640
-2% -$314K 0.03% 570
2016
Q3
$19M Sell
224,154
-1,112
-0.5% -$93.4K 0.03% 581
2016
Q2
$18.3M Buy
225,266
+23,600
+12% +$1.8M 0.03% 588
2016
Q1
$14.4M Sell
201,666
-1,000
-0.5% -$67.1K 0.03% 651
2015
Q4
$14.4M Sell
202,666
-12,700
-6% -$854K 0.03% 637
2015
Q3
$13.2M Sell
215,366
-79,160
-27% -$5.53M 0.03% 642
2015
Q2
$21.4M Sell
294,526
-127,800
-30% -$9.44M 0.04% 512
2015
Q1
$32.5M Sell
422,326
-32,250
-7% -$2.31M 0.06% 371
2014
Q4
$30.5M Buy
454,576
+37,900
+9% +$2.39M 0.06% 362
2014
Q3
$25.3M Sell
416,676
-9,458
-2% -$583K 0.05% 394
2014
Q2
$25M Buy
426,134
+123,048
+41% +$7.21M 0.04% 420
2014
Q1
$17.6M Buy
303,086
+99,450
+49% +$5.33M 0.03% 528
2013
Q4
$10.9M Sell
203,636
-29,830
-13% -$1.77M 0.02% 666
2013
Q3
$14.4M Buy
233,466
+7,397
+3% +$443K 0.03% 542
2013
Q2
$13.7M Buy
+226,069
New +$13.5M 0.03% 545

Other funds holding DGX

Prudential Financial's DGX Position: Q1 2026 in Review

Prudential Financial reduced its Quest Diagnostics (DGX) stake by 1.2% in Q1 2026, selling an estimated $130K and leaving 55,482 shares worth $10.9M. The position accounts for 0.01% of the portfolio, ranked #599.

Prudential Financial first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $64M in Q3 2024. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Prudential Financial held 55,482 shares of Quest Diagnostics worth $10.9M as of Q1 2026.
  • Prudential Financial sold 671 Quest Diagnostics shares in Q1 2026, an estimated $130K.
  • Quest Diagnostics made up 0.01% of Prudential Financial's portfolio in Q1 2026, its #599 holding.
  • Prudential Financial first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Prudential Financial's Quest Diagnostics position peaked at $64M in Q3 2024.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.